JP7585227B2 - Ｔｒｐｃ６阻害剤 - Google Patents

Ｔｒｐｃ６阻害剤 Download PDF

Info

Publication number
JP7585227B2
JP7585227B2 JP2021560094A JP2021560094A JP7585227B2 JP 7585227 B2 JP7585227 B2 JP 7585227B2 JP 2021560094 A JP2021560094 A JP 2021560094A JP 2021560094 A JP2021560094 A JP 2021560094A JP 7585227 B2 JP7585227 B2 JP 7585227B2
Authority
JP
Japan
Prior art keywords
trpc6
mmol
group
compounds
int
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021560094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022527618A5 (https=
JP2022527618A (ja
Inventor
ディルク ゴッチュリング
ティエリー ブーイスー
ニクラス ハイネ
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2022527618A publication Critical patent/JP2022527618A/ja
Publication of JP2022527618A5 publication Critical patent/JP2022527618A5/ja
Application granted granted Critical
Publication of JP7585227B2 publication Critical patent/JP7585227B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2021560094A 2019-04-12 2020-04-07 Ｔｒｐｃ６阻害剤 Active JP7585227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19168845 2019-04-12
EP19168845.6 2019-04-12
PCT/EP2020/059854 WO2020208002A1 (en) 2019-04-12 2020-04-07 Inhibitors of trpc6

Publications (3)

Publication Number Publication Date
JP2022527618A JP2022527618A (ja) 2022-06-02
JP2022527618A5 JP2022527618A5 (https=) 2023-04-12
JP7585227B2 true JP7585227B2 (ja) 2024-11-18

Family

ID=66175186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560094A Active JP7585227B2 (ja) 2019-04-12 2020-04-07 Ｔｒｐｃ６阻害剤

Country Status (5)

Country Link
US (1) US12156874B2 (https=)
EP (1) EP3959206A1 (https=)
JP (1) JP7585227B2 (https=)
CN (1) CN113677673B (https=)
WO (1) WO2020208002A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11485740B2 (en) * 2018-02-15 2022-11-01 Boehringer Ingelheim International Gmbh Inhibitors of TRPC6
WO2020208002A1 (en) 2019-04-12 2020-10-15 Boehringer Ingelheim International Gmbh Inhibitors of trpc6
EP4135696A1 (en) * 2020-04-16 2023-02-22 Boehringer Ingelheim International GmbH Inhibitors of trpc6 for treating respiratory conditions
AU2022366192A1 (en) * 2021-10-15 2024-02-29 Boehringer Ingelheim International Gmbh Trpc6 inhibitory compounds for treating sepsis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019081637A1 (en) 2017-10-27 2019-05-02 Boehringer Ingelheim International Gmbh CARBONYL PYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USES AS TRPC6 INHIBITORS
WO2019161010A1 (en) 2018-02-16 2019-08-22 Boehringer Ingelheim International Gmbh Inhibitors of trpc6

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60230266D1 (de) * 2001-06-15 2009-01-22 Astellas Pharma Inc Phenylpyridincarbonyl piperazinderivate
CN107253952B (zh) * 2017-08-01 2019-07-30 烟台大学 具有抗胃癌活性的trpc6抑制剂及其制备方法和用途
WO2019169168A1 (en) 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using agathobaculum
WO2020208002A1 (en) 2019-04-12 2020-10-15 Boehringer Ingelheim International Gmbh Inhibitors of trpc6

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019081637A1 (en) 2017-10-27 2019-05-02 Boehringer Ingelheim International Gmbh CARBONYL PYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USES AS TRPC6 INHIBITORS
WO2019161010A1 (en) 2018-02-16 2019-08-22 Boehringer Ingelheim International Gmbh Inhibitors of trpc6

Also Published As

Publication number Publication date
CN113677673B (zh) 2024-03-05
CN113677673A (zh) 2021-11-19
WO2020208002A1 (en) 2020-10-15
JP2022527618A (ja) 2022-06-02
US12156874B2 (en) 2024-12-03
EP3959206A1 (en) 2022-03-02
US20220152023A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
JP7217273B6 (ja) ピリジンカルボニル誘導体およびｔｒｐｃ６阻害剤としてのその治療的使用
US11370771B2 (en) Inhibitors of TRPC6
JP7291711B2 (ja) Ｔｒｐｃ６阻害剤
JP7585227B2 (ja) Ｔｒｐｃ６阻害剤
EP4705296A1 (en) Heteroarylindole inhibitors of apol-1
HK40045092A (en) Pyridine derivatives and therapeutic uses thereof as trpc6 inhibitors
HK40045092B (en) Pyridine derivatives and therapeutic uses thereof as trpc6 inhibitors
WO2025231011A1 (en) Heteroarylindole inhibitors of apol-1
HK40035138B (en) Inhibitors of trpc6
HK40035138A (en) Inhibitors of trpc6

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230403

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230403

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241007

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241106

R150 Certificate of patent or registration of utility model

Ref document number: 7585227

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150